NDC 70518-2014-3 - Buprenorphine HCl
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-2014
- Requested NDC
- 70518-2014-3
- Package NDCs from labels
- 70518-2014-0, 70518-2014-1, 70518-2014-3, 70518-2014-2
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-03-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Buprenorphine HCl - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-03-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-2014-0 | Buprenorphine HCl | 30 in 1 BLISTER PACK | TABLET | 30 | 17 | |
| 70518-2014-1 | Buprenorphine HCl | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 17 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-2014 | BUPRENORPHINE HCL TABLET [REMEDYREPACK INC.] | 13 | Current NDC, Legacy NDC, 2 package rows | 20250306_69a647c0-bc09-4ee2-aeb3-ef286caf25e5.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70518-2014-0 | EA - Each | 70518-2014 | 69339bdd-9555-4c35-87d3-2ab025a9e637 | 1 | 2026-01-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Camber Pharmaceuticals, Inc. | 221195e4-de08-414c-af08-a611a74789de | 2026-01-30 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Atlantic Biologicals Corp. | 42d837ae-2578-46df-92d2-24774964aaad | 2026-01-28 | Adverse reactions | 1Q73Q2JULR XF417D3PSL |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Camber Pharmaceuticals, Inc. | 5ab2d4e4-3c8c-413a-b147-23eafbde313a | 2026-01-28 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine | BUPRENORPHINE | Hikma Pharmaceuticals USA Inc. | 1bf8b35a-b769-465c-a2f8-099868dfcd2f | 2026-01-24 | Warnings, Adverse reactions | ANDA078633 0054-0177 351265 351264 e59c3c4f-a9cc-412b-b001-b9e430f537c5 1bf8b35a-b769-465c-a2f8-099868dfcd2f 56W8MW3EN1 |
| BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | Redpharm Drug | 44f2e26f-4586-5204-e063-6394a90a47d5 | 2026-01-23 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine HCl | BUPRENORPHINE HCL | Camber Pharmaceuticals, Inc. | b52cea0e-688f-4beb-bf7d-f228b81dbd23 | 2026-01-23 | Warnings, Adverse reactions | 351265 351264 56W8MW3EN1 |
| INSULIN DILUTING MEDIUM FOR Kirsty | WATER | Biocon Biologics Inc. | 3db1d482-7e1f-aec6-79ef-3f305b4d8277 | 2026-01-20 | Warnings, Adverse reactions | 059QF0KO0R |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Mylan Pharmaceuticals Inc. | 557d8d4d-8751-431c-b18e-9d5cf23fc579 | 2026-01-15 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-01-14 | Warnings | 059QF0KO0R |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Dr.Reddys Laboratories Inc | 718756d7-0131-b173-6c45-5ee039b311b0 | 2026-01-12 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Dr.Reddys Laboratories Inc | 72dc1ec0-7c59-a587-4ffd-c40ef79e6fb2 | 2026-01-12 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine | BUPRENORPHINE | AvPAK | 1408cd8f-a0b5-6be7-e063-6394a90a0b41 | 2026-01-08 | Warnings, Adverse reactions | 351265 351264 56W8MW3EN1 |
| Buprenorphine HCl and Naloxone HCl | BUPRENORPHINE AND NALOXONE | AvPAK | b955054b-b37d-4079-4fed-5939b763ecb4 | 2026-01-08 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Plus Rinse Emergency Eyewash | PURIFIED WATER | INNOVATIVE SAFETY SUPPLY INC. | b3f47d26-39e4-4aea-bb92-358def52b652 | 2026-01-08 | Warnings | 059QF0KO0R |
| pH Neutral Emergency Eyewash | WATER | INNOVATIVE SAFETY SUPPLY INC. | 29a1bd1e-d0dd-478f-e063-6394a90ab0aa | 2026-01-08 | Warnings | 059QF0KO0R |
| Cell Energy Performance Drops 2048 | CELL ENERGY PERFORMANCE DROPS | Professional Complementary Health Formulas | 8701ea61-5d5f-466b-8d2c-f808e7b4d8fe | 2026-01-08 | Warnings | XF417D3PSL |
| Metab 6012 | METAB | Professional Complementary Health Formulas | f3576d6f-c9ab-4370-8a32-b6c4bf6ba4fd | 2026-01-08 | Warnings | XF417D3PSL |
| Herbal Diuretic Liquescence 3011 | HERBAL DIURETIC LIQUESCENCE | Professional Complementary Health Formulas | 5eee7f21-a3c4-46e0-a642-a4ca635734e3 | 2026-01-08 | Warnings | XF417D3PSL |
| BELBUCA | BUPRENORPHINE HYDROCHLORIDE | BioDelivery Sciences International Inc | bc2b7a3d-72cf-497c-95b0-ba2b71f63c64 | 2026-01-02 | Boxed warning, Warnings, Adverse reactions | 56W8MW3EN1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.